logo
Lifestyle measures to improve your heart health

Lifestyle measures to improve your heart health

Yahoo18-02-2025

THIS month commemorates National Heart Month which serves to raise awareness of health conditions related to heart and circulatory disease and promote lifestyle measures to improve your cardiovascular health.
There are approximately 7.6 million people living with a heart or circulatory condition in the UK.
Coronary heart disease is the most common type and accounts for more than 170,000 deaths each year which is an average of 480 deaths each day or one every three minutes in the UK.
There are approximately 100,000 hospital admissions each year due to heart attacks in the UK.
Around 1.4 million people in the UK have survived a heart attack and almost a million people have heart failure.
The main risk factors for coronary heart disease include a high cholesterol level, high blood pressure and having an irregular heartbeat called atrial fibrillation.
Other risk factors include diabetes, being overweight or obese, having a family history of heart disease affecting first-degree relatives aged under 60 years, smoking tobacco, severe mental illness and taking anti-psychotic medications, poverty and deprivation, ethnicity with the condition being more common in black, Asian and minority ethnic groups, rheumatoid arthritis, using anabolic steroids for bodybuilding and suffering from migraines.
Common symptoms of cardiovascular disease include chest pain, feeling short of breath, lightheaded or dizzy, swollen ankles or feet and experiencing palpitations which is a conscious awareness of your heartbeat.
Other symptoms commonly associated with chest pain often found in patients with heart disease include the pain spreading to your left arm, neck or jaw, sweating, feeling nauseous and vomiting.
However, some patients with heart disease, especially those with diabetes, may have no symptoms.
Heart disease can also affect the young — each day in the UK approximately 13 babies are diagnosed with a congenital heart defect which are structural abnormalities you're born with.
Furthermore, approximately 12 people aged under 35 years die each week from sudden cardiac death which is when someone dies of a cardiac arrest due to genetic abnormalities affecting the heart muscle or electrical circuits within the heart.
There's a lot you can do to enhance your cardiovascular health.
Exercise is essential and you should aim for at least 150 minutes of moderate exercise each week, such as walking, cycling or swimming.
Additionally, diet plays a big role in improving heart health.
Incorporating more fruit, vegetables, whole grains and lean proteins while reducing processed foods, salt, saturated fats and refined sugars lowers your risk of coronary artery disease. Drinking red wine in moderation lowers your risk of coronary artery disease and may explain the French paradox.
This is the comparatively low rate of coronary artery disease in France compared with other Western countries despite the generally high intake of saturated fat in the French diet.
Stopping smoking and learning to constructively manage stress and anger through meditation, yoga and relaxation techniques are key to lowering your risk of cardiovascular disease.
Measuring your blood pressure at home and having your cholesterol levels checked are important in lowering your risk of heart disease.
Early detection and treatment of both of these significantly lowers your risk of a heart attack or stroke.
There are almost 30,000 out-of-hospital cardiac arrests each year in the UK.
Cardiac arrest is a condition where the heart stops beating and commonly happens at home.
There's lots you can do to help during heart month.
Learning cardiopulmonary resuscitation, commonly termed CPR, can be done in as little as 15 minutes and can save the life of someone in cardiac arrest by doubling to tripling the chances of survival until they reach hospital.
There has been massive pioneering advances in cardiovascular medicine in the last decade with new diagnostic technologies and treatments available to improve the health of your heart and circulation.
I would urge all patients concerned about their cardiovascular health to consult their GP.
Our columnist Dr Jason Seewoodhary is a former Worcestershire GP.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why has there been a global surge of new Covid variant NB.1.8.1?
Why has there been a global surge of new Covid variant NB.1.8.1?

Yahoo

time40 minutes ago

  • Yahoo

Why has there been a global surge of new Covid variant NB.1.8.1?

India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.

Why has there been a global surge of new Covid variant NB.1.8.1?
Why has there been a global surge of new Covid variant NB.1.8.1?

Yahoo

timean hour ago

  • Yahoo

Why has there been a global surge of new Covid variant NB.1.8.1?

India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.

New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin
New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin

Yahoo

time3 hours ago

  • Yahoo

New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin

SINGAPORE, June 10, 2025 /PRNewswire/ -- Japan's clinic-born leading derma-cosmetics brand, unveiled new findings at IMCAS Asia 2025, reaffirming its position as the go-to skincare brand for Asian skin. The data demonstrated the efficacy of VC100 Essence Lotion EX and 377VC Radiance Serum in improving skin hydration, elasticity, and pigmentation when used daily and post-IPL[1] care. "At IMCAS Asia 2025, we're proud to present new clinical evidence that reflects the needs of today's consumers and supports their aesthetic and skincare choices. Our role is to provide safe, effective skincare solutions like VC100 Essence Lotion EX and 377VC Radiance Serum that can be used as daily skincare, enhance recovery and extend results of aesthetic treatments," said Dr. Sheila Chua, Board-Certified Dermatologist and Head of Medical & Safety Sciences, Skin Health & Beauty, Kenvue Asia Pacific. VC100 Essence Lotion EX: Now with clinically proven efficacy for regular daily and post-IPL care At IMCAS Asia 2025, presented new clinical data highlighting the benefits of twice-daily use of VC100 Essence Lotion EX over eight weeks on Asian skin. Powered by 100 trillion Micro-High Penetrating APPS Vitamin C, the formulation delivered visible improvements across key skin indicators including hydration, elasticity and gloss by 21.6%, 14.6%, 8.7% respectively, and reduction in hyperpigmentation by 5.9%.[2] The study also showed a significant boost in the synthesis of five different types of collagen, increased collagen density, and skin firmness. This builds on findings presented at the American Academy of Dermatology 2025, where twice daily use of VC100 Essence Lotion EX and Emulsion over a span of eight weeks showed a similar trend of improvement to IPL.[3],[4] When used in combination with IPL, hydration and elasticity improved by 25.4% and 15.5% respectively, compared to 20.8% and 10.9% with IPL alone, and hyperpigmentation reduction accelerated, with visible improvement by Week Two. 377VC Radiance Serum: A proven brightening adjunct for IPL-treated skin also shared clinical data on 377VC Radiance Serum at IMCAS. In a five-week, randomized controlled trial, participants who used the serum daily post-IPL showed a 31.88% reduction in Melasma Area and Severity Index and a 22.13% reduction in hyperpigmentation, compared to 8.92% and 8.52% in participants that only received IPL.[5] Skin image analysis further indicates reversing and reduced risk of potential re-darkening after IPL. The serum was well tolerated on treated skin in favorable state, supporting its use in post-IPL care and reaffirming its safety profile.[5] Findings presented at IMCAS from a survey of 844 dermatologists in China validated clinical approach and reinforces its clinical credibility: 83% agreed that 377VC Radiance Serum reduces melanin synthesis and improves skin brightness, Over 75% believed it enhances post-IPL outcomes and helps prevent post-inflammatory hyperpigmentation, and 99% acknowledged growing patient demand for adjunctive clinical skincare.[6] For a detailed overview of products and posters exhibited, refer to the Data and Product Fact Sheet. For more information, visit the website. About Since 1999, has pioneered the advancement of skincare solutions in collagen health. For over 25 years, is dedicated to providing skincare solutions that unlock the potential for beauty within every skin and democratize access to clinic level treatments for all. [1] Intense Pulsed Laser [2] Taichi Nishizawa et. al., "Ex-vivo and Clinical Study of an Amphiphilic Vitamin C Derivative to Enhance Dermal Collagen and Skin Gloss", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand [3] Frequency of IPL treatment administered: 3 times every 2 weeks, over 8 weeks (IPL output: 10-13J, about 100 shots). [4] Masahiko Ando et. al., Clinical efficacy assessment of skin care formulations containing trisodium ascorbyl6-palmitate 2-phosphate (APPS) for pre-aging skin, Poster number 61671, American Academy of Dermatology Annual Meeting, 7-11 March 2025, Orlando, Florida [5] Yueying Fu et. al., "Clinical Safety and Efficacy of a Novel Topical Phenylethyl Resorcinol Formulation for Intense Pulsed Light Adjunctive Usage for Solar Lentigo and Melasma skin", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand [6] Joleen Goh et. al., "Knowledge, Attitude, and Practice Towards the Adjunctive Perioperative Use of Phenylethyl Resorcinol with Aesthetic Treatments", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand View original content to download multimedia: SOURCE Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store